Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice

Shigellosis is a diarrheal disease caused prevalently by <i>Shigella flexneri</i> and <i>S. sonnei</i> and representing a major global health risk, particularly in developing countries. Bacterial O-antigen (OAg) is the primary target of the host immune response and modificati...

Full description

Bibliographic Details
Main Authors: Vanessa Arato, Davide Oldrini, Luisa Massai, Gianmarco Gasperini, Francesca Necchi, Francesca Micoli
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/9/11/2360
_version_ 1797509231465725952
author Vanessa Arato
Davide Oldrini
Luisa Massai
Gianmarco Gasperini
Francesca Necchi
Francesca Micoli
author_facet Vanessa Arato
Davide Oldrini
Luisa Massai
Gianmarco Gasperini
Francesca Necchi
Francesca Micoli
author_sort Vanessa Arato
collection DOAJ
description Shigellosis is a diarrheal disease caused prevalently by <i>Shigella flexneri</i> and <i>S. sonnei</i> and representing a major global health risk, particularly in developing countries. Bacterial O-antigen (OAg) is the primary target of the host immune response and modifications of its oligosaccharide units, including O-acetylation, are responsible for the variability among the circulating <i>S. flexneri</i> serotypes. No vaccines are widely available against shigellosis and the understanding of the immunogenicity induced by the OAg is fundamental for the design of a vaccine that could cover the most prevalent <i>Shigella</i> serotypes. To understand whether a different O-acetylation pattern could influence the immune response elicited by <i>S. flexneri</i> OAg, we employed as a vaccine technology GMMA purified from <i>S. flexneri</i> 2a and 1b strains that were easily engineered to obtain differently O-acetylated OAg. Resulting GMMA were tested in mice, demonstrating not only no major impact of O-acetyl decorations on the immune response elicited by the two OAg against the homologous strains, but also that the O-acetylation of the Rhamnose III residue (O-factor 9), shared among serotypes 1b, 2a and 6, does not induce cross-reactive antibodies against these serotypes. This work contributes to the optimization of vaccine design against <i>Shigella</i>, providing indication about the ability of shared epitopes to elicit broad protection against <i>S. flexneri</i> serotypes and supporting the identification of critical quality attributes of OAg-based vaccines.
first_indexed 2024-03-10T05:14:46Z
format Article
id doaj.art-6c2d235a723a49bb93a91981c21a43de
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-10T05:14:46Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-6c2d235a723a49bb93a91981c21a43de2023-11-23T00:30:16ZengMDPI AGMicroorganisms2076-26072021-11-01911236010.3390/microorganisms9112360Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in MiceVanessa Arato0Davide Oldrini1Luisa Massai2Gianmarco Gasperini3Francesca Necchi4Francesca Micoli5GSK Vaccines Institute for Global Health, 53100 Siena, ItalyGSK Vaccines Institute for Global Health, 53100 Siena, ItalyGSK Vaccines Institute for Global Health, 53100 Siena, ItalyGSK Vaccines Institute for Global Health, 53100 Siena, ItalyGSK Vaccines Institute for Global Health, 53100 Siena, ItalyGSK Vaccines Institute for Global Health, 53100 Siena, ItalyShigellosis is a diarrheal disease caused prevalently by <i>Shigella flexneri</i> and <i>S. sonnei</i> and representing a major global health risk, particularly in developing countries. Bacterial O-antigen (OAg) is the primary target of the host immune response and modifications of its oligosaccharide units, including O-acetylation, are responsible for the variability among the circulating <i>S. flexneri</i> serotypes. No vaccines are widely available against shigellosis and the understanding of the immunogenicity induced by the OAg is fundamental for the design of a vaccine that could cover the most prevalent <i>Shigella</i> serotypes. To understand whether a different O-acetylation pattern could influence the immune response elicited by <i>S. flexneri</i> OAg, we employed as a vaccine technology GMMA purified from <i>S. flexneri</i> 2a and 1b strains that were easily engineered to obtain differently O-acetylated OAg. Resulting GMMA were tested in mice, demonstrating not only no major impact of O-acetyl decorations on the immune response elicited by the two OAg against the homologous strains, but also that the O-acetylation of the Rhamnose III residue (O-factor 9), shared among serotypes 1b, 2a and 6, does not induce cross-reactive antibodies against these serotypes. This work contributes to the optimization of vaccine design against <i>Shigella</i>, providing indication about the ability of shared epitopes to elicit broad protection against <i>S. flexneri</i> serotypes and supporting the identification of critical quality attributes of OAg-based vaccines.https://www.mdpi.com/2076-2607/9/11/2360<i>Shigella flexneri</i>O-antigenO-acetylationGMMA vaccine
spellingShingle Vanessa Arato
Davide Oldrini
Luisa Massai
Gianmarco Gasperini
Francesca Necchi
Francesca Micoli
Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
Microorganisms
<i>Shigella flexneri</i>
O-antigen
O-acetylation
GMMA vaccine
title Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
title_full Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
title_fullStr Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
title_full_unstemmed Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
title_short Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
title_sort impact of o acetylation on i s flexneri i 1b and 2a o antigen immunogenicity in mice
topic <i>Shigella flexneri</i>
O-antigen
O-acetylation
GMMA vaccine
url https://www.mdpi.com/2076-2607/9/11/2360
work_keys_str_mv AT vanessaarato impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice
AT davideoldrini impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice
AT luisamassai impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice
AT gianmarcogasperini impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice
AT francescanecchi impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice
AT francescamicoli impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice